Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Electrophysiology equipment analyzes the electrical activity of the heart. An electrophysiology ablation catheter contains an electrode on one end which emits RF waves to destroy a small area of heart tissue in the abnormal conduction pathway, blocking further channeling of the impulses causing the heart’s abnormal rhythm. GlobalData uses proprietary data and analytics to provide a comprehensive report on the electrophysiology ablation catheters devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the electrophysiology ablation catheters market in the UK was Biosense Webster followed by Abbott Laboratories, Medtronic, Boston Scientific, Biotronik SE and CardioFocus.
EP Ablation is applicable for a wide variety of arrhythmias and has an extremely high success rate with low rates of complication and recurrence. Standard and advanced ablation catheters are tracked under this segment. A standard ablation catheter contains a tip electrode through which RF energy is emitted. An advanced ablation catheter utilizes features and methods beyond those of standard ablation catheters.
Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the electrophysiology ablation catheters devices market within the UK was expected to be over $90m in 2022.
For the latest complete market share analysis of electrophysiology ablation catheters device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
